TOG Review (RCOG Journal)
MRCOG Part 2
Gynaecological Problems
Premenstrual disorders including premenstrual syndrome and premenstrual dysphoric disorder
Key Statistics
- 3–8% — Women with severe PMS/PMDD
- 86% — PMDD patients considering suicide
- 5 of 11 — DSM-5 symptoms needed (≥1 core)
Don't-miss facts
-
PMDD: ≥5 of 11 DSM-5 symptoms (≥1 core), confirmed by prospective diary over 2 cycles, before treatment starts
-
PMDD in ICD-11 (2019), code GA34.41 – genitourinary AND depressive disorder cross-listing
-
86% of PMDD patients have considered suicide, 30% have attempted – treat all PMD as suicidality risk
-
No symptom-free interval before ovulation = unlikely PMS/PMDD – consider premenstrual exacerbation of another disorder
-
Stepwise Rx: lifestyle/CBT/SSRI or COCP → SSRI+COCP or estrogen/progesterone → GnRHa ± add-back HRT → hysterectomy+BSO ± HRT
-
GnRHa >6 months needs add-back HRT + bone density monitoring; question diagnosis if no relief by 12 weeks
-
BSO essential with hysterectomy – unopposed estrogen otherwise risks symptom recurrence
-
Dutasteride 2.5mg/day blocks luteal allopregnanolone rise (2016 RCT) – reduces PMDD symptoms
First-line drug doses
Fluoxetine 20mg/day Sertraline 50–100mg/day Citalopram/Escitalopram 20mg/day Paroxetine 20mg/day
Drospirenone 3mg/EE 20mcg COCP 24/4
Abbreviation Key
- PMS — premenstrual syndrome
- DRSP/PRISM — Daily Record of the Severity of the Problem / Prospective Record of the Impact and Severity of Menstrual
- PMDD — premenstrual dysphoric disorder Symptoms
- PMD — premenstrual disorder
- CBT (iCBT) — cognitive behavioural therapy (internet-based)
- DSM-5 — Diagnostic and Statistical Manual of Mental Disorders, 5th
- SSRI/SNRI — selective serotonin / serotonin–noradrenaline reuptake edition inhibitor
- ICD-11 — International Classification of Diseases, 11th revision
- COCP (UKMEC) — combined oral contraceptive pill (UK Medical
- ISPMD — International Society for Premenstrual Disorders Eligibility Criteria)
- NAPS — National Association for Premenstrual Syndromes
- VTE — venous thromboembolism
- IAPMD — International Association for Premenstrual Disorders
- LNG-IUS — levonorgestrel intrauterine system
- CNS/GABA — central nervous system / gamma-aminobutyric acid
- HRT — hormone replacement therapy
- ESR1 — estrogen receptor 1 gene (SNP = single nucleotide polymorphism)
- GnRH(a) — gonadotrophin-releasing hormone (agonist)
- BSO — bilateral salpingo-oophorectomy
- fMRI/MR — functional / magnetic resonance imaging
- VAC — Vitex agnus castus
- MAO — monoamine oxidase
- GAMSA — GABAA modulating steroid antagonist
- MDT — multidisciplinary team
- DALYs / USS — disability-adjusted life years / ultrasound scan
Source: Goswami N et al. Premenstrual disorders including premenstrual syndrome and premenstrual dysphoric disorder. The Obstetrician & Gynaecologist 2023;25:38–46. doi:10.1111/tog.12848
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).